Loss-of-function mutations in the Sost gene lead to high bone mass phenotypes. Pharmacological inhibition of Sost/sclerostin provides a new drug strategy for treating osteoporosis. Questions remain as to how physical activity may affect bone mass under sclerostin inhibition and if that effect differs between males and females. We previously observed in female Sost knockout (KO) mice an enhanced cortical bone formation response to a moderate level of applied loading (900 με at the tibial midshaft). The purpose of the present study was to examine cortical bone adaptation to the same strain level applied to male Sost KO mice. Strain-matched in vivo compressive loading was applied to the tibiae of 10-, 26- and 52-week-old male Sost KO and litte...
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone fo...
AbstractMechanical loading is the primary functional determinant of bone mass and architecture, and ...
Sclerostin, the Wnt signaling antagonist encoded by the Sost gene, is secreted by osteocytes and inh...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at matura...
A new therapeutic option to treat osteoporosis is focused on Wnt signaling and its inhibitor scleros...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at maturat...
Sclerostin, a product of the Sost gene, is a Wnt-inhibitor and thus negatively regulates bone accrua...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, encoded by the Sost gene, is an important negative regulator of bone formation that has ...
Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone m...
Osteogenesis imperfecta (OI), which is most often due to a collagen type 1 gene mutation, is charact...
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone fo...
AbstractMechanical loading is the primary functional determinant of bone mass and architecture, and ...
Sclerostin, the Wnt signaling antagonist encoded by the Sost gene, is secreted by osteocytes and inh...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at matura...
A new therapeutic option to treat osteoporosis is focused on Wnt signaling and its inhibitor scleros...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at maturat...
Sclerostin, a product of the Sost gene, is a Wnt-inhibitor and thus negatively regulates bone accrua...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, encoded by the Sost gene, is an important negative regulator of bone formation that has ...
Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone m...
Osteogenesis imperfecta (OI), which is most often due to a collagen type 1 gene mutation, is charact...
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone fo...
AbstractMechanical loading is the primary functional determinant of bone mass and architecture, and ...
Sclerostin, the Wnt signaling antagonist encoded by the Sost gene, is secreted by osteocytes and inh...